PORTLAND, ME. – October 5, 2016 – RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.

https://www.rxante.com/health-plans/rxante-to-fuel-growth-with-equity-investment-from-upmc-enterprises-millennium-health-sells-entire-interest-in-analytics-company/

"Mosaic combines technology with a comprehensive clinical care model to create outcomes unlike other pharmacies. Therapeutic Decision Support™ (TDS), powered by RxAnte’s analytics, helps Mosaic pharmacists optimize our members’ medication regimens. Supported by this technology, we can better coordinate with prescribers to add, remove, or change medications to maximize therapeutic effect, while ensuring the patient is paying the lowest possible copays for their medications."

https://www.rxante.com/health-plans/answering-frequently-asked-questions-with-mosaics-director-of-clinical-services/